FDA Acknowledgment Letter to Mykyta Sukhenko

This document consists of an acknowledgment letter from the FDA's Division of Management and Budget (DMB) to Mykyta Sukhenko, dated March 20, 2026. The letter, originating from the Center for Devices and Radiological Health (CDRH), confirms receipt of a submission. While the content is restricted due to Personally Identifiable Information (PII) in one version, a redacted version is also available.

This notice serves as confirmation of FDA's receipt of a submission from Mykyta Sukhenko. Regulated entities, particularly those interacting with the CDRH, should note this as a standard procedural communication. No immediate action is required by other parties based on this acknowledgment, but it signifies that a submission has entered the FDA's review process.